Washington, July 20 -- Congressman Kevin Mullin issued the following press release:
The Trump Administration's undermining of the U.S. Food and Drug Administration (FDA) is putting public health at risk and threatening advancements in the life sciences industry, prompting Rep. Kevin Mullin (CA-15) to call for more stability at the agency.
This week, Rep. Mullin sounded the alarm during an Energy and Commerce subcommittee meeting, which coincided with his sending a letter to the FDA that calls out the Administration's harmful policies effecting its work. The FDA's crisis stems from mass layoffs, that led to a nearly 20% reduction in staff last year and tumultuous leadership turnover, which have weakened the agency's ability to protect cons...